However, the recent FDA approval of Evolysse Form and Smooth, the company’s entry into the hyaluronic acid (HA) dermal filler market ... The company expects fillers to contribute 8-10% of ...

However, the recent FDA approval of Evolysse Form and Smooth, the company’s entry into the hyaluronic acid (HA) dermal filler market, has significantly expanded Evolus ... on this trend with its newly ...